Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of rocuronium on ET50 of sevoflurane to blunt cardiovascular responses to tracheal intubation
ChiCTR2000040952Phase 4Recruiting
- Sponsor
- First Hospital of China Medical University
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of rocuronium in None (2 arms), sponsored by First Hospital of China Medical University. Primary endpoint: Induction time (ET50) to blunt cardiovascular responses to tracheal intubation. Started Dec 2020; status: recruiting.
02
Drugs
rocuronium
Beyond the preview
Go deeper on ChiCTR2000040952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040952.